Anti-CXCL13 antibodies and method of using same

Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.

Saved in:
Bibliographic Details
Main Authors PARIS MARK, KLIMATCHEVA EKATERINA, SMITH ERNEST S
Format Patent
LanguageChinese
English
Published 09.10.2013
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.
Bibliography:Application Number: CN201180052932